CorMedix (CRMD): Investor reports 4.62M shares, 5.89% stake

Rhea-AI Filing Summary

CorMedix Inc. ownership disclosure: Aymen Abdalkader Shaibata (a Saudi Arabia citizen) reports beneficial ownership of 4,618,511 shares of Common Stock, representing 5.89% of the class. The filing is an amendment to a Schedule 13G/A and is signed on 06/12/2026.

The form lists voting and dispositive power as sole for 4,618,511 shares. The filing provides a snapshot of a single investor's position rather than a transaction record.

Insights

Corporate Governance Analyst

Schedule 13G/A discloses a 5.89% beneficial stake by an individual investor.

The filing shows 4,618,511 shares beneficially owned with sole voting and sole dispositive power as stated in the ownership table. The signature date is 06/12/2026, and the form type is an amendment to a Schedule 13G/A.

Holding-level disclosures like this are routine regulatory transparency measures; cash‑flow treatment and any acquisition timing are not stated in the provided excerpt. Subsequent filings would show any changes in ownership.

Key Figures

Beneficial ownership: 4,618,511 shares Percent of class: 5.89% Filing type: Schedule 13G/A amendment

3 metrics

Beneficial ownership 4,618,511 shares Amount beneficially owned as reported on the Schedule 13G/A

Percent of class 5.89% Percent of class reported in the filing

Filing type Schedule 13G/A amendment Amendment signed on <date>06/12/2026</date>

Key Terms

Schedule 13G/A, Beneficial ownership, Sole Voting Power

3 terms

Schedule 13G/A regulatory

"An amendment to a Schedule 13G/A is cited at the top of the excerpt"

A Schedule 13G/A is an amended public filing with the U.S. securities regulator that updates a previous Schedule 13G, disclosing when an individual or group holds a substantial (typically over 5%) stake in a company and is claiming a passive, non‑controlling intent. Investors monitor these updates because rising or falling holdings can signal changing confidence, potential future moves, or shifts in voting power — like watching a public ledger where large shareholders quietly adjust their positions.

Beneficial ownership financial

"Item 4 lists 'Amount beneficially owned: 4,618,511' as reported"

Beneficial ownership means the person or entity that actually enjoys the benefits of owning shares or other assets — such as receiving dividends, voting rights, or price gains — even if the legal title is held in another name. For investors it matters because knowing who truly controls and profits from a company reveals who can influence decisions, exposes potential conflicts of interest or hidden concentration of power, and affects transparency and risk in the stock.

Sole Voting Power governance

"Column shows 'Sole Voting Power 4,618,511.00' in the ownership table"

Sole voting power is the exclusive right to cast votes attached to a shareholder’s stock without needing approval from anyone else. Like holding the only remote control for a TV, it lets that holder decide corporate matters such as board members, mergers, and policy changes, making it important to investors because it concentrates control and can strongly influence a company’s strategy and the value of its shares.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 06/12/2026 - 01:07 PM Accepted by SEC EDGAR 06/12/2026 - 01:07 PM Learn about SEC filing dates

FAQ

What stake does SHAIBATALHAMD AYMEN ABDALKADER report in CorMedix (CRMD)?

He reports beneficial ownership of 4,618,511 shares, equal to 5.89% of common stock, as declared on the Schedule 13G/A. The filing lists sole voting and sole dispositive power over those shares.

What form was filed to report this ownership in CRMD?

An amendment to a Schedule 13G/A was filed and signed on 06/12/2026. The form type indicates a passive investor disclosure rather than a Form 4 insider trade report.

Does the filing show any share transactions or purchases?

No transaction details are provided; the Schedule 13G/A lists current beneficial ownership of 4,618,511 shares. The filing functions as a position disclosure, not a trade record.

What voting and dispositive powers are reported for these CRMD shares?

The filing states sole power to vote for 4,618,511 shares and sole power to dispose of 4,618,511 shares, with no shared voting or dispositive power indicated.

Where is the filing signer located and what is their citizenship?

The signer’s address is listed in Riyadh, Saudi Arabia, and citizenship is stated as Saudi Arabia in the Schedule 13G/A signature block.

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 13G

UNDER THE SECURITIES EXCHANGE ACT OF 1934

(Amendment No. 4)

CorMedix Inc.

(Name of Issuer)

COMMON STOCK, PAR V ALUE $0.001 PER SHARE

(Title of Class of Securities)

21900C308

(CUSIP Number)

06/11/2026

(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

Rule 13d-1(b)

Rule 13d-1(c)

Rule 13d-1(d)

schemaVersion:

SCHEDULE 13G

CUSIP Number(s): 21900C308

1

Names of Reporting Persons

SHAIBATALHAMD AYMEN ABDALKADER

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 4,618,511.00
6	Shared Voting Power
7	Sole Dispositive Power 4,618,511.00
8	Shared Dispositive Power

9

Aggregate Amount Beneficially Owned by Each Reporting Person

4,618,511.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

5.9 %

12

Type of Reporting Person (See Instructions)

IN

SCHEDULE 13G

Item 1.
(a)	Name of issuer: CorMedix Inc.
(b)	Address of issuer's principal executive offices: 389 INTERPACE PKWY, SUITE 450, PARSIPPANY, NEW JERSEY, 07054
Item 2.
(a)	Name of person filing: SHAIBATALHAMD AYMEN ABDALKADER
(b)	Address or principal business office or, if none, residence: 7852, Al Batinah, 2650, Al Woroud Dist., Riyadh 12253, Saudi Arabia
(c)	Citizenship: Saudi Arabia
(d)	Title of class of securities: COMMON STOCK, PAR V ALUE $0.001 PER SHARE
(e)	CUSIP No.: 21900C308
Item 3.	If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
(a)	Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
(b)	Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
(c)	Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
(d)	Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
(e)	An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
(f)	An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
(g)	A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
(h)	A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
(i)	A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
(j)	A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J), please specify the type of institution:
(k)	Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
Item 4.	Ownership
(a)	Amount beneficially owned: 4,618,511
(b)	Percent of class: 5.89 %
(c)	Number of shares as to which the person has:
	(i) Sole power to vote or to direct the vote: 4,618,511
	(ii) Shared power to vote or to direct the vote:
	(iii) Sole power to dispose or to direct the disposition of: 4,618,511
	(iv) Shared power to dispose or to direct the disposition of:
Item 5.	Ownership of 5 Percent or Less of a Class.
	Not Applicable
Item 6.	Ownership of more than 5 Percent on Behalf of Another Person.
	Not Applicable
Item 7.	Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
	Not Applicable
Item 8.	Identification and Classification of Members of the Group.
	Not Applicable
Item 9.	Notice of Dissolution of Group.
	Not Applicable

Item 10.	Certifications:
	Not Applicable

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

SHAIBATALHAMD AYMEN ABDALKADER

Signature:	SHAIBATALHAMD AYMEN ABDALKADER
Name/Title:	Individual
Date:	06/12/2026